clarithromycin has been researched along with B16 Melanoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gota, V; Mehta, M; Patel, K; Patil, A; Vavia, P | 1 |
| Aoyama, S; Azuma, A; Hino, M; Kokubo, Y; Kudo, S; Matsuda, K; Shibuya, M; Shu, D | 1 |
| Aoki, S; Fukuno, Y; Hayashi, S; Kawashima, M; Nagata, M; Taniguchi, S; Tominaga, M; Tsuruta, N; Yatsunami, J | 1 |
3 other study(ies) available for clarithromycin and B16 Melanoma
| Article | Year |
|---|---|
Oral delivery of paclitaxel nanocrystal (PNC) with a dual Pgp-CYP3A4 inhibitor: preparation, characterization and antitumor activity.
Topics: Administration, Oral; Animals; Antineoplastic Agents, Phytogenic; Arginine; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chickens; Clarithromycin; Cyclosporine; Cytochrome P-450 CYP3A Inhibitors; Drug Compounding; Gastrointestinal Tract; Hypromellose Derivatives; Ileum; Melanoma, Experimental; Mice; Nanoparticles; Paclitaxel; Particle Size; Rats, Sprague-Dawley; Skin Neoplasms; Surface Properties; Tumor Burden | 2014 |
[Effects of clarithromycin on experimental pulmonary metastasis].
Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Immunologic Factors; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred BALB C | 1997 |
Roxithromycin and clarithromycin, 14-membered ring macrolides, potentiate the antitumor activity of cytotoxic agents against mouse B16 melanoma cells.
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Cisplatin; Clarithromycin; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Drug Synergism; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Roxithromycin; Skin Neoplasms; Tumor Cells, Cultured; Vindesine | 1999 |